Newsroom-Katalog
Zeit | Boehringer Ingelheim: Meldungen vom 25.10.2007 |
---|---|
14:10 | New Three-Year Data Confirms Aptivus(R) (tipranavir) as Effective and Durable Treatment Option for Treatment-Experienced Patients |
Zeit | Boehringer Ingelheim: Meldungen vom 25.10.2007 |
---|---|
14:10 | New Three-Year Data Confirms Aptivus(R) (tipranavir) as Effective and Durable Treatment Option for Treatment-Experienced Patients |